期刊
ISCIENCE
卷 21, 期 -, 页码 188-+出版社
CELL PRESS
DOI: 10.1016/j.isci.2019.10.020
关键词
-
资金
- Foundation for Strategic Research [FFL12-0220]
- Swedish Cancer Society
- Swedish Childhood Cancer Fund
- Swedish Research Council
- King Gustaf V Jubilee Fund
- Karolinska Institutet
- Swedish Foundation for Strategic Research (SSF) [FFL12-0220] Funding Source: Swedish Foundation for Strategic Research (SSF)
In pediatric neuroblastoma, MYCN-amplification correlates to poor clinical outcome and new treatment options are needed for these patients. Identifying the metabolic adaptations crucial for tumor progression may be a promising strategy to discover novel therapeutic targets. Here, we have combined proteomics, gene expression profiling, functional analysis, and metabolic tracing to decipher the impact of MYCN on neuroblastoma cell metabolism. We found that high MYCN levels are correlated with altered expression of proteins involved in multiple metabolic processes, including enhanced glycolysis and increased oxidative phosphorylation. Unexpectedly, we discovered that MYCN-amplified cells showed de novo glutamine synthesis. Furthermore, inhibition of ft-oxidation reduced the viability of MYCN-amplified cells in vitro and decreased tumor burden in vivo, while not affecting non-MYCN-amplified tumors. Our data provide information on metabolic processes in MYCN expressing tumors, which could be exploited for the development of novel targeted therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据